Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Feeling wonder every day improves our health. Here’s how to do it. - 2Hand Skin Is Additionally Significant - What You Ought to Realize About Hand Cream
- 3Damaged launch pad: How long before Russia can send astronauts to the ISS again?
- 4New Jordan security fence could be done in early 2028
- 5What is ‘Auld Lang Syne’? Why we sing this song at midnight on New Year’s Eve.
- NASA unveils close-up pictures of the comet popping by from another star
- Overhaul Your Rest: Tips for a Serene Evening
- Partake in the Outside: Senior-Accommodating Exercises for 2024
- The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
- Barn Stored Lotus Esprit Turbo Seen After 30 Years
- Instructions to Comprehend and Use Open Record Extra Offers
- It's been 20 years since MTV's golden couple split. These producers saw it all unravel.
- Newly Built Sichuan Hydropower Bridge Collapses Into River Months After Opening
- Find the Effect of Web-based Entertainment on Psychological wellness: Exploring the Advanced Scene Securely
